01 13D IMAGING DRUG DESIGN AND DEVELOPMENT LLC
01 1ZR89 OXINE
01 1U.S.A
01 1Active
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36161
Submission : 2021-08-09
Status : Active
Type : II
20
3d Imaging Drug Design And Development Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ZR89 OXINE, with a corresponding US DMF Number 36161.
Remarkably, this DMF maintains an Active status since its submission on August 09, 2021, highlighting commitment to regulatory compliance.
